Bertrand L. Chenard

1.0k total citations
28 papers, 668 citations indexed

About

Bertrand L. Chenard is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Bertrand L. Chenard has authored 28 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 11 papers in Molecular Biology and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Bertrand L. Chenard's work include Neuroscience and Neuropharmacology Research (10 papers), Bioactive Compounds and Antitumor Agents (6 papers) and Oxidative Organic Chemistry Reactions (5 papers). Bertrand L. Chenard is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Bioactive Compounds and Antitumor Agents (6 papers) and Oxidative Organic Chemistry Reactions (5 papers). Bertrand L. Chenard collaborates with scholars based in United States, United Kingdom and Canada. Bertrand L. Chenard's co-authors include Frank S. Menniti, John S. Swenton, James E. Krause, Daniel N. Cortright, Michael A. Petti, T. V. RajanBabu, Martin J. Pagnozzi, Mary Collins, William F. White and Willard M. Welch and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Stroke.

In The Last Decade

Bertrand L. Chenard

28 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bertrand L. Chenard United States 15 257 256 235 67 55 28 668
Sanath K. Meegalla United States 21 299 1.2× 315 1.2× 298 1.3× 52 0.8× 75 1.4× 38 1.4k
Alan Hutchison Switzerland 17 228 0.9× 388 1.5× 323 1.4× 47 0.7× 18 0.3× 24 761
Sylvain Célanire France 13 216 0.8× 341 1.3× 127 0.5× 60 0.9× 51 0.9× 24 572
Martin Lochner Switzerland 14 202 0.8× 491 1.9× 159 0.7× 42 0.6× 129 2.3× 47 874
Lars J. S. Knutsen Denmark 17 665 2.6× 603 2.4× 259 1.1× 61 0.9× 14 0.3× 36 1.2k
David J. Hallett United Kingdom 17 124 0.5× 390 1.5× 478 2.0× 72 1.1× 37 0.7× 26 906
Joseph W. Gunnet United States 19 173 0.7× 277 1.1× 211 0.9× 29 0.4× 14 0.3× 43 974
Peter Ström Sweden 13 349 1.4× 313 1.2× 69 0.3× 51 0.8× 42 0.8× 23 772
Eric Vieira Switzerland 18 542 2.1× 825 3.2× 430 1.8× 73 1.1× 18 0.3× 25 1.4k
Brian Scott United States 15 160 0.6× 337 1.3× 401 1.7× 244 3.6× 65 1.2× 24 1.0k

Countries citing papers authored by Bertrand L. Chenard

Since Specialization
Citations

This map shows the geographic impact of Bertrand L. Chenard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertrand L. Chenard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertrand L. Chenard more than expected).

Fields of papers citing papers by Bertrand L. Chenard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertrand L. Chenard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertrand L. Chenard. The network helps show where Bertrand L. Chenard may publish in the future.

Co-authorship network of co-authors of Bertrand L. Chenard

This figure shows the co-authorship network connecting the top 25 collaborators of Bertrand L. Chenard. A scholar is included among the top collaborators of Bertrand L. Chenard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertrand L. Chenard. Bertrand L. Chenard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hodgetts, Kevin J., Charles A. Blum, Timothy M. Caldwell, et al.. (2010). Pyrido[2,3-b]pyrazines, discovery of TRPV1 antagonists with reduced potential for the formation of reactive metabolites. Bioorganic & Medicinal Chemistry Letters. 20(15). 4359–4363. 10 indexed citations
2.
Cortright, Daniel N., Robin Meade, Stephen M. Waters, Bertrand L. Chenard, & James E. Krause. (2009). C5a, But Not C3a, Increases VEGF Secretion in ARPE-19 Human Retinal Pigment Epithelial Cells. Current Eye Research. 34(1). 57–61. 41 indexed citations
3.
Luke, George P., et al.. (2008). An Efficient Preparation of β-Aryl-β-ketophosphonates by the TFAA/H3PO4-Mediated Acylation of Arenes with Phosphonoacetic Acids. The Journal of Organic Chemistry. 73(16). 6397–6400. 14 indexed citations
4.
Blum, Charles A., Xiaozhang Zheng, Harry L. Brielmann, et al.. (2008). Aminoquinazolines as TRPV1 antagonists: Modulation of drug-like properties through the exploration of 2-position substitution. Bioorganic & Medicinal Chemistry Letters. 18(16). 4573–4577. 13 indexed citations
5.
Wustrow, David J., George D. Maynard, Jun Yuan, et al.. (2008). Aminopyrazine CB1 receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters. 18(11). 3376–3381. 7 indexed citations
6.
Chandrasekhar, Jayaraman, David C. Ihle, David J. Wustrow, et al.. (2008). 1-Benzylbenzimidazoles: The discovery of a novel series of bradykinin B1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(18). 5027–5031. 9 indexed citations
7.
Krause, James E. & Bertrand L. Chenard. (2008). Opportunities and Challenges in the Discovery of New Central Nervous System Drugs. Annals of the New York Academy of Sciences. 1144(1). 243–250. 3 indexed citations
8.
Han, Bingsong, et al.. (2007). Development of a Scaleable Synthesis of NDT 9533750, a Key Intermediate to a Series of Novel Subtype Preferring GABAA Partial Agonists. Organic Process Research & Development. 11(4). 716–720. 1 indexed citations
9.
Krause, James E., Bertrand L. Chenard, & Daniel N. Cortright. (2005). Transient receptor potential ion channels as targets for the discovery of pain therapeutics.. PubMed. 6(1). 48–57. 44 indexed citations
10.
Waters, Stephen M., Robbin Brodbeck, Jeremy Steflik, et al.. (2005). Molecular Characterization of the Gerbil C5a Receptor and Identification of a Transmembrane Domain V Amino Acid That Is Crucial for Small Molecule Antagonist Interaction. Journal of Biological Chemistry. 280(49). 40617–40623. 22 indexed citations
11.
Chenard, Bertrand L., Willard M. Welch, James F. Blake, et al.. (2001). Quinazolin-4-one α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonists:  Structure−Activity Relationship of the C-2 Side Chain Tether. Journal of Medicinal Chemistry. 44(11). 1710–1717. 37 indexed citations
12.
Menniti, Frank S., Martin J. Pagnozzi, Paul Butler, et al.. (2000). CP-101,606, an NR2B subunit selective NMDA receptor antagonist, inhibits NMDA and injury induced c-fos expression and cortical spreading depression in rodents. Neuropharmacology. 39(7). 1147–1155. 49 indexed citations
13.
Menniti, Frank S., Bertrand L. Chenard, Mary B. Collins, et al.. (2000). Characterization of the Binding Site for a Novel Class of Noncompetitive α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Antagonists. Molecular Pharmacology. 58(6). 1310–1317. 44 indexed citations
14.
Menniti, Frank S., Bertrand L. Chenard, Mary B. Collins, et al.. (2000). Characterization of the Binding Site for a Novel Class of Noncompetitive α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Antagonists. Molecular Pharmacology. 58(6). 1310–1317. 5 indexed citations
15.
Menniti, Frank S., Ajit Shah, Stephen A. Williams, et al.. (1998). CP‐101,606: An NR2B‐Selective NMDA Receptor Antagonist. CNS Drug Reviews. 4(4). 307–322. 18 indexed citations
16.
17.
Menniti, Frank S., et al.. (1997). CP-101,606, a potent neuroprotectant selective for forebrain neurons. European Journal of Pharmacology. 331(2-3). 117–126. 92 indexed citations
18.
Chenard, Bertrand L., et al.. (1981). Synthesis and chemistry of 2-trimethylsilylbenzocyclobutenones. Journal of the Chemical Society Chemical Communications. 179–179. 10 indexed citations
19.
Chenard, Bertrand L., et al.. (1980). Organocopper chemistry of quinone bisketals. Application to the synthesis of isoprenoid quinone systems. The Journal of Organic Chemistry. 45(3). 378–384. 19 indexed citations
20.
Chenard, Bertrand L. & John S. Swenton. (1979). Electrochemical oxidations of benzo[b]thiophens: a simple route to benzo[b]thiophen-4,7-quinone bis- and mono-acetals. Journal of the Chemical Society Chemical Communications. 1172–1172. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sanath K. Meegalla Breakdown of academic impact, for papers by Alan Hutchison Breakdown of academic impact, for papers by Sylvain Célanire Breakdown of academic impact, for papers by Martin Lochner Breakdown of academic impact, for papers by Lars J. S. Knutsen Breakdown of academic impact, for papers by David J. Hallett Breakdown of academic impact, for papers by Joseph W. Gunnet Breakdown of academic impact, for papers by Peter Ström Breakdown of academic impact, for papers by Eric Vieira Breakdown of academic impact, for papers by Brian Scott
Rankless by CCL
2026